Raymond James Trust N.A. Has $22.61 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Raymond James Trust N.A. lowered its position in Aflac Incorporated (NYSE:AFL - Free Report) by 43.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 202,275 shares of the financial services provider's stock after selling 156,281 shares during the quarter. Raymond James Trust N.A.'s holdings in Aflac were worth $22,614,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of AFL. Strategic Financial Concepts LLC increased its holdings in shares of Aflac by 7,001.0% during the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider's stock valued at $596,000 after acquiring an additional 658,303 shares during the last quarter. International Assets Investment Management LLC raised its position in shares of Aflac by 10,878.5% in the third quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider's stock valued at $62,597,000 after purchasing an additional 554,803 shares during the period. Truist Financial Corp raised its position in shares of Aflac by 26.6% in the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider's stock valued at $172,338,000 after purchasing an additional 405,847 shares during the period. Swedbank AB bought a new stake in shares of Aflac during the 1st quarter worth $27,588,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider's stock worth $429,319,000 after buying an additional 285,576 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Price Performance

Shares of NYSE:AFL traded up $0.82 on Friday, hitting $112.55. The stock had a trading volume of 757,825 shares, compared to its average volume of 2,210,819. The firm's 50 day moving average price is $110.66 and its 200-day moving average price is $100.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The company has a market capitalization of $62.52 billion, a price-to-earnings ratio of 16.88, a price-to-earnings-growth ratio of 2.14 and a beta of 0.96.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts' consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company's revenue for the quarter was down 40.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.84 earnings per share. On average, equities research analysts predict that Aflac Incorporated will post 7.22 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.78%. Aflac's dividend payout ratio (DPR) is presently 30.12%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Piper Sandler boosted their target price on shares of Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Barclays started coverage on Aflac in a research report on Wednesday, September 4th. They set an "underweight" rating and a $96.00 price objective for the company. Evercore ISI raised their target price on Aflac from $84.00 to $90.00 and gave the company an "underperform" rating in a report on Thursday, September 26th. Morgan Stanley upped their price target on Aflac from $91.00 to $98.00 and gave the stock an "equal weight" rating in a report on Monday, August 19th. Finally, UBS Group increased their target price on shares of Aflac from $84.00 to $109.00 and gave the company a "neutral" rating in a research note on Wednesday, August 14th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $97.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.